BRANDI QUEEN: Open Payments
NPI 1558670604 · MARSHVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 39 payments from 10 companies in 2025. Trend: 2023 $416 · 2024 $601 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $222 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Exact Sciences Corporation | 3 | $65 |
| Corcept Therapeutics | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| Amgen Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: Wegovy, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Korlym, MOUNJARO, Saxenda, Ozempic, FARXIGA.
Industry payments across NC — which companies pay providers there.
